S Laban1, M Brand2, J Ezić2, J Doescher2, G Völkel3, H A Kestler3, C Brunner2, T K Hoffmann2. 1. Kopf-Hals-Tumorzentrum Ulm, Klinik für Hals-Nasen-Ohrenheilkunde, und Kopf-Hals-Chirurgie, Universitätsklinik Ulm, Frauensteige 12, 87070, Ulm, Deutschland. simon.laban@uniklinik-ulm.de. 2. Kopf-Hals-Tumorzentrum Ulm, Klinik für Hals-Nasen-Ohrenheilkunde, und Kopf-Hals-Chirurgie, Universitätsklinik Ulm, Frauensteige 12, 87070, Ulm, Deutschland. 3. Institut für Medizinische Systembiologie, Universität Ulm, Ulm, Deutschland.
Abstract
BACKGROUND: Etiologically, oropharyngeal squamous cell carcinoma (OPSCC) can be divided into OPSCC caused by noxious agents and human papillomavirus (HPV)-driven carcinoma. These types differ with regard to clinical features and prognosis-differences which are rooted in the underlying molecular biology of the tumor. OBJECTIVE: The aim of this work is to provide an overview of the molecular biological characteristics of the genetics, epigenetics, and immunology of OPSCC. MATERIALS AND METHODS: A literature review was performed on a selection of genetic, epigenetic, and immunological factors characterizing OPSCC. RESULTS: The understanding of genetic aberrations and their consequences for cancerogenesis and tumor biology is increasing. Epigenetic phenomena are complementing functional relationships. However, epigenetic mechanisms of gene regulation are complex and much research is still required in this field. Immunological aspects of cancer molecular biology have moved into the focus in light of recent advances in the field of immunotherapy. CONCLUSION: The tumor biology of OPSCC is primarily defined by its HPV status. Additionally, HPV-independent genetic, epigenetic, and immunological signatures are being defined. From these advances, rationales for new treatment concepts may evolve.
BACKGROUND: Etiologically, oropharyngeal squamous cell carcinoma (OPSCC) can be divided into OPSCC caused by noxious agents and human papillomavirus (HPV)-driven carcinoma. These types differ with regard to clinical features and prognosis-differences which are rooted in the underlying molecular biology of the tumor. OBJECTIVE: The aim of this work is to provide an overview of the molecular biological characteristics of the genetics, epigenetics, and immunology of OPSCC. MATERIALS AND METHODS: A literature review was performed on a selection of genetic, epigenetic, and immunological factors characterizing OPSCC. RESULTS: The understanding of genetic aberrations and their consequences for cancerogenesis and tumor biology is increasing. Epigenetic phenomena are complementing functional relationships. However, epigenetic mechanisms of gene regulation are complex and much research is still required in this field. Immunological aspects of cancer molecular biology have moved into the focus in light of recent advances in the field of immunotherapy. CONCLUSION: The tumor biology of OPSCC is primarily defined by its HPV status. Additionally, HPV-independent genetic, epigenetic, and immunological signatures are being defined. From these advances, rationales for new treatment concepts may evolve.
Entities:
Keywords:
Biomarkers, tumor; Epigenetics; Medical genetics; Molecular medicine; Oropharyngeal neoplasms
Authors: K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison Journal: N Engl J Med Date: 2010-06-07 Impact factor: 91.245
Authors: Martina A Broglie; Wolfram Jochum; Angelika Michel; Tim Waterboer; Diana Foerbs; René Schoenegg; Sandro J Stoeckli; Michael Pawlita; Dana Holzinger Journal: Oral Oncol Date: 2017-05-25 Impact factor: 5.337
Authors: Nam Bui; Justin K Huang; John Paul Shen; Ana Bojorquez-Gomez; Katherine Licon; Kyle S Sanchez; Sean N Tang; Alex N Beckett; Tina Wang; Wei Zhang; Jason F Kreisberg; Trey Ideker Journal: Mol Cancer Ther Date: 2018-04-10 Impact factor: 6.261
Authors: Rachel E Bell; Tamar Golan; Danna Sheinboim; Hagar Malcov; David Amar; Avi Salamon; Tamar Liron; Sahar Gelfman; Yankel Gabet; Ron Shamir; Carmit Levy Journal: Genome Res Date: 2016-02-23 Impact factor: 9.043